Brimonidine Tartrate Ophthalmic Solution, 0.15% Solution/ Drops
Product Images NDC 46708-661

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate Ophthalmic Solution, 0.15% (NDC 46708-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-bottle-10ml (Brimonidine Bottle 10ml)

Brimonidine-bottle-10ml (Brimonidine Bottle 10ml)
This text appears to be a description of an ophthalmic solution containing the active ingredient Brimonidine Tartrate. The solution comes in a concentration of 0.15% and is used to treat affected eyes. The recommended dosage is one drop three times a day. The solution is preserved with a complex named "tabiized oxychioro". The storage instructions indicate that the solution should be stored at a temperature between 15°C and 25°C (59°F to 77°F). The manufacturer of this ophthalmic solution is Alembic Pharmaceuticals Limited, located in Karakhadi, Gujarat, India. The text also includes additional information such as the NDC (National Drug Code) number and the manufacturing batch number and expiration date. Please note that the text is partially illegible, containing some distorted characters.*
FDA Label Image

Brimonidine-bottle-15ml (Brimonidine Bottle 15ml)

Brimonidine-bottle-15ml (Brimonidine Bottle 15ml)
This text appears to be a description of an ophthalmic solution containing Brimonidine Tartrate. The solution is used for treating eye conditions and contains a concentration of 0.15% Biimonidine tartrate as the active ingredient. It also mentions the presence of a stabilized oxychloro complex as a preservative in a concentration of 0.005%. The recommended dosage is one drop three times a day to the affected eye(s). The solution should be stored at a temperature of 15°C to 25°C (59°F to 77°F). The text also provides information about the manufacturer, Alembic Pharmaceuticals Limited, located in Karakhadi, Gujarat, India. The manufacturer's lot number and expiration date are also mentioned.*
FDA Label Image

Brimonidine-bottle-5ml (Brimonidine Bottle 5ml)

Brimonidine-bottle-5ml (Brimonidine Bottle 5ml)
Not available.*
FDA Label Image

Brimonidine-carton-10ml (Brimonidine Carton 10ml)

FDA Label Image

Brimonidine-carton-15ml (Brimonidine Carton 15ml)

FDA Label Image

Brimonidine-carton-5ml (Brimonidine Carton 5ml)

FDA Label Image

Brimonidine-structure (Brimonidine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.